141 related articles for article (PubMed ID: 10865040)
1. Management of hyperthyroidism due to Graves' and nodular diseases.
Okamoto T; Iihara M; Obara T
World J Surg; 2000 Aug; 24(8):957-61. PubMed ID: 10865040
[TBL] [Abstract][Full Text] [Related]
2. Graves' disease with an autonomously functioning thyroid nodule: case report.
Jabrocka-Hybel A; Gołkowski F; Bałdys-Waligórska A; Sokołowski G; Hubalewska-Dydejczyk A
Pol Arch Med Wewn; 2009; 119(7-8):505-8. PubMed ID: 19776692
[TBL] [Abstract][Full Text] [Related]
3. [Marine-Lenhart syndrome: a case observation upon 18 years].
Waldherr C; Otte A; Haldemann A; Müller-Brand J
Nuklearmedizin; 1999; 38(8):345-8. PubMed ID: 10615671
[TBL] [Abstract][Full Text] [Related]
4. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
5. Current approach to surgical management of hyperthyroidism.
Barczyński M
Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):124-131. PubMed ID: 33494587
[TBL] [Abstract][Full Text] [Related]
6. Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any).
Bartalena L; Chiovato L; Vitti P
J Endocrinol Invest; 2016 Oct; 39(10):1105-14. PubMed ID: 27319009
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of surgical management of hyperthyroidism: 15-year experience from a tertiary care center in a developing country.
Pradeep PV; Agarwal A; Baxi M; Agarwal G; Gupta SK; Mishra SK
World J Surg; 2007 Feb; 31(2):306-12; discussion 313. PubMed ID: 17219271
[TBL] [Abstract][Full Text] [Related]
8. Benign thyroid disease: what is the role of nuclear medicine?
Sarkar SD
Semin Nucl Med; 2006 Jul; 36(3):185-93. PubMed ID: 16762609
[TBL] [Abstract][Full Text] [Related]
9. A patient with an autonomously functioning thyroid nodule with papillary adenocarcinoma associated with Graves' hyperthyroidism.
Tsuboi M; Shigemasa C; Ueta Y; Yoshida A; Kobayashi K; Mori T; Mashiba H
Clin Nucl Med; 1995 Nov; 20(11):985-8. PubMed ID: 8565381
[TBL] [Abstract][Full Text] [Related]
10. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
[TBL] [Abstract][Full Text] [Related]
11. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
Bürgi U; Gerber H; Peter HJ
Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of hyperthyroidism.
Quérat C; Germain N; Dumollard JM; Estour B; Peoc'h M; Prades JM
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Apr; 132(2):63-6. PubMed ID: 25592327
[TBL] [Abstract][Full Text] [Related]
13. Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy.
Cappelli C; Braga M; De Martino E; Castellano M; Gandossi E; Agosti B; Cumetti D; Pirola I; Mattanza C; Cherubini L; Rosei EA
Surg Today; 2006; 36(2):125-30. PubMed ID: 16440157
[TBL] [Abstract][Full Text] [Related]
14. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
Jukić T; Stanicić J; Petric V; Kusić Z
Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options.
Bunevicius R; Prange AJ
CNS Drugs; 2006; 20(11):897-909. PubMed ID: 17044727
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of an autonomously functioning thyroid nodule in a patient with Graves' disease: an unusual presentation of Marine-Lenhart syndrome.
Nishikawa M; Yoshimura M; Yoshikawa N; Toyoda N; Yonemoto T; Ogawa Y; Mori S; Tabata S; Tokoro T; Sakaguchi N; Inada M
Endocr J; 1997 Aug; 44(4):571-4. PubMed ID: 9447292
[TBL] [Abstract][Full Text] [Related]
17. Thyroid nodules in Graves' disease: classification, characterization, and response to treatment.
Carnell NE; Valente WA
Thyroid; 1998 Aug; 8(8):647-52. PubMed ID: 9737358
[TBL] [Abstract][Full Text] [Related]
18. Thyroid nodules in Graves' disease: classification, characterization, and response to treatment.
Carnell NE; Valente WA
Thyroid; 1998 Jul; 8(7):571-6. PubMed ID: 9709909
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
20. Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study.
Cramon P; Winther KH; Watt T; Bonnema SJ; Bjorner JB; Ekholm O; Groenvold M; Hegedüs L; Feldt-Rasmussen U; Rasmussen ÅK
Thyroid; 2016 Aug; 26(8):1010-8. PubMed ID: 27370744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
